Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01126047 · ClinicalTrials.gov registry record · NA

Exhaled Carbon Monoxide (eCO) for Diffusing Capacity (DLCO) Correction

A NA study of Lung Diseases, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
100
Enrollment target
2
Study locations

NCT01126047 is a NA study of Lung Diseases that has completed, run by University of California, Los Angeles. The registered enrollment target is 100 participants, below the 736-participant average among 31 other Lung Diseases trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01126047, a NA study of Lung Diseases, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to check the accuracy of a procedure called exhaled carbon monoxide (eCO) testing. Exhaled carbon monoxide is used by physicians to help assess breathing in people with conditions like asthma and emphysema. eCO may be used to correct another breathing test (called diffusing capacity, or DLCO). Blood collection is usually required to correct the DLCO, so validation of the eCO test may help avoid that blood collection.

Conditions Studied

Lung Diseases

Interventions

  • OTHER eCO testing

Study Locations (2)

California

  • UCLA - Los Angeles
  • West LA VA - Los Angeles

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2010-05
Est. Completion 2011-11
Phase NA

Sponsor

University of California, Los Angeles

897 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01126047

The ClinicalTrials.gov registry entry for NCT01126047 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 736-participant average among 31 other Lung Diseases trials with a reported enrollment target (86% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Diseases appearing as the primary indexed condition, and to 1 intervention - of which eCO testing is the first listed.

NCT01126047 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01126047 about?

NCT01126047 is a clinical study titled "Exhaled Carbon Monoxide (eCO) for Diffusing Capacity (DLCO) Correction". The purpose of this study is to check the accuracy of a procedure called exhaled carbon monoxide (eCO) testing. Exhaled carbon monoxide is used by physicians to help assess breathing in people with conditions like asthma and emphysema. eCO may be used to correct another breathing test (called diffus...

What is the current status of trial NCT01126047?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2010-05. Estimated completion is 2011-11.

What conditions does trial NCT01126047 study?

This clinical trial studies the following conditions: Lung Diseases.

What interventions are being tested in trial NCT01126047?

The interventions under investigation include: eCO testing (OTHER).

Who is sponsoring clinical trial NCT01126047?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01126047 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Diseases

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.